University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Stephen D. McLeod, M.D.

Ophthalmologist

Dr. Stephen D. McLeod, chair of the Ophthalmology department at UCSF, specializes in refractive, or vision correction, surgery and corneal disease. In his research, he has focused on the development of an intraocular lens to restore near vision to patients undergoing cataract surgery.

McLeod earned a medical degree at Johns Hopkins University School of Medicine in Baltimore, Md. After completing an ophthalmology residency at the Illinois Eye and Ear Infirmary at the University of Illinois, Chicago, he completed fellowship training in cornea, external disease and refractive surgery at the University of Southern California's Doheny Eye Institute. He is chair of the Preferred Practice Pattern (PPP) Panel on Refractive Surgery for the American Academy of Ophthalmology and is a consultant to the Ophthalmic Devices Panel of the Food and Drug Administration (FDA). He also is a member of the editorial board of the American Medical Association's journal for ophthalmology research, Archives of Ophthalmology.

Conditions & Treatments

Clinics

Corneal Disease and Surgery
8 Koret Way, Suite U-545
San Francisco, CA 94143
Phone: (415) 514–8200
Fax: (415) 514–6845

Laser Vision Center
8 Koret Way, Room U-519
San Francisco, CA 94143–0644
Phone: (415) 353–2020
Fax: (415) 514–6892

Hours: Monday to Friday, 8 a.m. – 5 p.m.

More about Stephen D. McLeod

Education

Johns Hopkins School of Medicine 1989

Residencies

Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Ophthalmology 1993

Fellowships

USC Doheny Eye Institute, Cornea, External Eye Disease and Refractive Surgery 1994

Selected Research and Publications

  1. Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, Kumar JA, Mascarenhas J, Margolis TP, Whitcher JP, Jeng BH, Keenan JD, Chan MF, McLeod SD, Acharya NR. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012; 53(4):1787-91.
  2. Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Cevallos V, Oldenburg CE, Ray KJ, Toutain-Kidd CM, Glidden DV, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infect Dis. 2012 May; 54(10):1381-7.
  3. Lalitha P, Lin CC, Srinivasan M, Mascarenhas J, Prajna NV, Keenan JD, McLeod SD, Acharya NR, Lietman TM, Porco TC. Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics. Ophthalmic Epidemiol. 2012 Apr; 19(2):111-5.
  4. Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Pseudomonas aeruginosa Keratitis: Outcomes and Response to Corticosteroid Treatment. Invest Ophthalmol Vis Sci. 2012 Jan; 53(1):267-72.
  5. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR. The steroids for corneal ulcers trial: study design and baseline characteristics. Arch Ophthalmol. 2012 Feb; 130(2):151-7.
  6. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012 Feb; 130(2):143-50.
  7. Oldenburg CE, Keenan JD, Cevallos V, Chan MF, Acharya NR, Gaynor BD, McLeod SD, Esterberg EJ, Porco TC, Lietman TM. Microbiological cure times in acanthamoeba keratitis. Eye (Lond). 2011 Sep; 25(9):1155-60.
  8. Horton JC, Yoon MK, Carvalho MD, McLeod SD. Polymerase chain reaction confirmed by immunohistochemistry: a two-pronged diagnostic approach in endophthalmitis. Acta Ophthalmol. 2011 May; 89(3):301-2.
  9. Lalitha P, Shapiro BL, Loh AR, Fothergill AW, Prajna NV, Srinivasan M, Oldenburg CE, Quigley DA, Chidambaram JD, McLeod SD, Acharya NR, Lietman TM. Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis. Br J Ophthalmol. 2011 May; 95(5):744-5.
  10. Yoon MK, Naseri A, Porco T, McLeod SD. Nepafenac-assisted mydriasis in a rabbit model. J Cataract Refract Surg. 2010 Oct; 36(10):1779-82.
  11. Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M, Vaitilingam CM, Hong KC, Lee SM, McLeod SD, Zegans ME, Porco TC, Lietman TM, Acharya NR. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010 Jun; 128(6):672-8.
  12. Keenan JD, Fram NR, McLeod SD, Strauss EC, Margolis TP. Perifosine-related rapidly progressive corneal ring infiltrate. Cornea. 2010 May; 29(5):583-5.
  13. Naseri A, McLeod SD. Cataract surgery after refractive surgery. Curr Opin Ophthalmol. 2010 Jan; 21(1):35-8.
  14. Acharya NR, Srinivasan M, Mascarenhas J, Ravindran M, Rajaraman R, Zegans M, McLeod S, Lietman TM. The steroid controversy in bacterial keratitis. Arch Ophthalmol. 2009 Sep; 127(9):1231.
  15. Day S, Lalitha P, Haug S, Fothergill AW, Cevallos V, Vijayakumar R, Prajna NV, Acharya NR, McLeod SD, Lietman TM. Activity of antibiotics against Fusarium and Aspergillus. Br J Ophthalmol. 2009 Jan; 93(1):116-9.
  16. Srinivasan M, Lalitha P, Mahalakshmi R, Prajna NV, Mascarenhas J, Chidambaram JD, Lee S, Hong KC, Zegans M, Glidden DV, McLeod S, Whitcher JP, Lietman TM, Acharya NR. Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol. 2009 Feb; 93(2):198-202.
  17. Chen ES, Terry MA, Shamie N, Phillips PM, Friend DJ, McLeod SD. Descemet-stripping automated endothelial keratoplasty: insertion using a novel 40/60 underfold technique for preservation of donor endothelium. Cornea. 2008 Sep; 27(8):941-3.
  18. Diaz-Aleman VT, Anton A, de la Rosa MG, Johnson ZK, McLeod S, Azuara-Blanco A. Detection of visual-field deterioration by Glaucoma Progression Analysis and Threshold Noiseless Trend programs. Br J Ophthalmol. 2009 Mar; 93(3):322-8.
  19. Chen A, Prajna L, Srinivasan M, Mahalakshmi R, Whitcher JP, McLeod S, Lietman TM, Acharya NR. Does in vitro susceptibility predict clinical outcome in bacterial keratitis? Am J Ophthalmol. 2008 Mar; 145(3):409-412.
  20. Schmidt GW, Yoon M, McGwin G, Lee PP, McLeod SD. Evaluation of the relationship between ablation diameter, pupil size, and visual function with vision-specific quality-of-life measures after laser in situ keratomileusis. Arch Ophthalmol. 2007 Aug; 125(8):1037-42.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.